VTGN
Vistagen·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VTGN Filings
Filing Date
Form Description
Form Type
2025-12-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-04
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2025-12-04 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2025-12-03
Form 8-K - Current report
Key Events
2025-12-03 · Key Events
Form 8-K - Current report
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call Transcript
Earnings Call
2025-11-13 · Earnings Call
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call Transcript
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
